Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
2.550
+0.380 (17.51%)
At close: Dec 24, 2025, 1:00 PM EST
2.580
+0.030 (1.18%)
After-hours: Dec 24, 2025, 4:58 PM EST
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $109.61 million as of December 24, 2025. Its market cap has decreased by -18.14% in one year.
Market Cap
109.61M
Enterprise Value
-2.65M
1-Year Change
-18.14%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $109.61M, a decrease of -88.41%. That is a compound annual growth rate of -32.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 93.28M | 67.50% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
| Jun 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 969.95B |
| Johnson & Johnson | 496.19B |
| AbbVie | 405.97B |
| UnitedHealth Group | 295.96B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 263.79B |
| Novo Nordisk | 232.28B |